# Study to Evaluate the Pharmacokinetics and Pharmacodynamics of AZD4604 Given Via the Turbuhaler® Device in Adults With Mild Asthma.

> **NCT06732882** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 28 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** AZD4604
- **OTHER:** Placebo
- **DEVICE:** Genuair
- **DEVICE:** Turbuhaler

## Key facts

- **NCT ID:** NCT06732882
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-27
- **Primary completion:** 2025-05-29
- **Final completion:** 2025-05-29
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2025-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06732882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06732882, "Study to Evaluate the Pharmacokinetics and Pharmacodynamics of AZD4604 Given Via the Turbuhaler® Device in Adults With Mild Asthma.". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06732882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*